Print Page   |   Sign In   |   Join!
News & Press
Filter news by category:

PSHP Newsletters

Displaying page 1 of 2
1  |  2

Student Submissions
Monday, May 13, 2019
Our Experience as Second Year Pharmacy Students at the PSHP Student Jeopardy Competition »
Authors: Emily Farina & Monica Woloshin, Jefferson College of Pharmacy Class of 2021 Faculty Advisor: Bhavik Shah...
Friday, April 19, 2019
A New Breakthrough in Migraine Treatment – Aimovig (erenumab) »
Allison Tempo, Doctor of Pharmacy Candidate Duquesne University School of Pharmacy David E. Zimmerman, PharmD, BCPS,...
Wednesday, March 20, 2019
Ivosidenib (Tibsovo®) for the treatment of relapsed and refractory acute myeloid leukemia »
Ivosidenib (Tibsovo®) for the treatment of relapsed and refractory acute myeloid leukemia in patients with an isocitrat...
Monday, February 11, 2019
Use of Apixaban in Patients with Nonvalvular Atrial Fibrillation and End Stage Renal Disease »
Boluwatife Familusi, PharmD Candidate 2020, Jefferson College of Pharmacy Preceptor: Raymond Lamore, PharmD, BCPS,...
Monday, December 17, 2018
Succinylcholine and Prolonged Muscle Paralysis with Apnea: An Adverse Drug Reaction Case Report »
Adeline Cruz, PharmD Candidate 2019, Temple University School of Pharmacy  Stanislav Gluhov,  Phar...
Monday, November 26, 2018
Angiotensin II (Giapreza®) - Intravenous Therapy for the Treatment of Septic Shock »
Joyce Jung, PharmD Candidate 2019, Philadelphia College of Pharmacy Oludamilola Olugbile, PharmD, Clinical Pharmacis...
Monday, November 26, 2018
What the MERINO Study Results Mean for the Future of Antibiotic Resistance »
Lakyn Husinka, Doctor of Pharmacy Candidate 2019, Duquesne university School of Pharmacy     Backgrou...
Monday, November 26, 2018
Redefining the Standard: A Review of the SMART and SALT-ED Trials »
Eileen Friery, Doctor of Pharmacy Candidate 2019, Wilkes University Nesbitt School of Pharmacy Amanda Holyk, PharmD, BC...
Thursday, October 18, 2018
Andexxa: First Reversal Agent for Anti-Factor Xa Inhibitors »
Xinwei Li, PharmD Candidate 2019 Philadelphia College of Pharmacy, University of the Sciences in Philadelphia...
Tuesday, September 18, 2018
A New ExeCUTIoner: Plazomicin for complicated UTIs »
Nick Hastain, PharmD Candidate 2019, Jefferson College of Pharmacy Preceptor: Oludamilola Olugbile, PharmD, Clinical...
Wednesday, August 8, 2018
Aspirin for the Prevention of Colorectal Cancer »
Rachel Hatch, PharmD Candidate 2019, Philadelphia College of Pharmacy Natalie Greco, PharmD Candidate 2019, Philadelphia...
Sunday, July 15, 2018
Have you “C-een-the-DIFFerence” in the 2018 Clostridioides difficile Guidelines? »
Have you “C-een-the-DIFFerence” in the 2018 Clostridioides difficile Guidelines ? Brooke Barlow & Ash...
Wednesday, June 20, 2018
Phage Therapy: A Potential Solution to Multidrug-Resistant Bacteria »
Joshua Hildebrand, Pharm.D. Candidate 2020, Duquesne University Dr. David E. Zimmerman, Pharm.D., BCPS, BCCCP I...
Wednesday, May 23, 2018
Alirocumab (Praluent®)– New Role in Lipid Lowering Therapy »
Quynh-Nhu Truong, PharmD Candidate 2019, Philadelphia College of Pharmacy Faculty Advisor: Laura Waite, PharmD, BCPS, CL...
Thursday, April 19, 2018
Treatment of Acute Migraine Headache in the Emergency Department »
Madelyn Stabinski, Duquesne University PharmD Candidate of 2020 David E. Zimmerman, PharmD, BCPS, BCCCP, Assistant Prof...
Thursday, December 21, 2017
Carbapenem-Resistant Enterobacteriaceae (CRE): Where Are We Now and Where Are We Going? »
Student Submission By: Brendan Mangan, Pharm.D. Candidate 2018, Stacy Pasciolla, Pharm.D. Candidate 2018, Jason Gallagher,...
Tuesday, November 21, 2017
Parsabiv ® (etelcalcetide) - the first intravenous drug approved for the treatment of secondary hype »
Mandee Noval, PharmD Candidate 2018 Cole Cecchini, PharmD Candidate 2019 Preceptor - Nicole M. Sifontis, PharmD...
Friday, October 20, 2017   (0 Comments - view/add)
A Student’s Perspective on ASHP Policy Week »
A Student’s Perspective on ASHP Policy Week Brittany Tschaen Pharm.D. Candidate 2018 Jefferson College of...
Tuesday, September 19, 2017   (0 Comments - view/add)
Parsabiv ® (etelcalcetide) - the first intravenous drug approved for the treatment of secondary hype »
Parsabiv ® (etelcalcetide) - the first intravenous drug approved for the treatment of secondary hyperthyroidism in chronic...
Tuesday, September 19, 2017
Cinqair (reslizumab): A new add-on maintenance treatment for patients with eosinophilic phenotype wi »
Cinqair (reslizumab): A new add-on maintenance treatment for patients with eosinophilic phenotype with severe asthma...
Tuesday, September 19, 2017
FDA New Drug Approval: VoseviTM for Hepatitis C therapy in treatment-experienced adults »
FDA New Drug Approval: Vosevi TM for Hepatitis C therapy in treatment-experienced adults Christine Starrs, P...
Tuesday, August 22, 2017
Transitions in a Student Run Clinic »
Student Submission -  Transitions in a Student Run Clinic Bailey Colvin, Doctor of Pharmacy Candidate 2018 Nico...
Monday, July 24, 2017
Historical Impacts of Generic Drug Regulation »
Student Submission - Historical Impacts of Generic Drug Regulation By: Stephanie Liu, PharmD Candidate 2017 Precepto...
Friday, June 30, 2017
Class 1 Drugs, Repurposed Rather Than New »
Student Submission: Class 1 Drugs, Repurposed Rather Than New Jose B. Fernandez Jr., PharmD Class of 2019 Roger Ar...
Thursday, May 18, 2017
Drug review: Descovy »
Student Submission: Drug review: Descovy Christine A. Dimaculangan is a 6th year pharmacy student at the Philadel...
Thursday, April 27, 2017
Bridion®: The First Selective Relaxant Binding Agent for Reversal of Neuromuscular Blockade »
Student Submission: Bridion®: The First Selective Relaxant Binding Agent for Reversal of Neuromuscular Blockade Author:...
Thursday, March 30, 2017
Call for Student Submissions: Guidelines for Submitting your Article to the PSHP Newsletter! »
PSHP Newsletter Article Submission Guidelines How would you like to… Polish your writing skills for f...
Friday, February 24, 2017   (0 Comments - view/add)
The New Hospital-Acquired and Ventilator-Associated Pneumonia Guidelines: A Review of Notable Change »
Jordan Gabrielsen, PharmD Candidate 2018 Preceptor: Raymond Lamore, PharmD, BCPS  The Infectious Disease Soci...
Tuesday, January 31, 2017
Student Submission: Daclizumab – A New Option for Relapsing Multiple Sclerosis »
Anna Krupa, PharmD Candidate 2017 Carol Ly, PharmD Candidate 2018 Jennifer Andres, PharmD, BCPS – Faculty Advisor...
Friday, December 23, 2016   (0 Comments - view/add)
Different Perspectives of American Society of Health-System Pharmacists (ASHP) Mid-Year: A Closer Lo »
Different Perspectives of American Society of Health-System Pharmacists (ASHP) Mid-Year: A Closer Look from P3 to Resident...
Friday, December 2, 2016   (0 Comments - view/add)
How pharmacy students across PA came together to promote PAI »
By: Jenna L. Fancher, M.A. PharmD Candidate 2017 Background       &nb...
Tuesday, November 1, 2016   (0 Comments - view/add)
Talimogene laherparepvec (T-VEC): The first oncolytic virus in the treatment of unresectable melano »
Author: Chris Dorian, PCP PharmD Class of 2019 Faculty Advisor: Nicole Schroeder PharmD,BCPS,BCCCP, Assistant Prof....
Friday, September 30, 2016   (1 Comment - view/add)
Empliciti »
Marijanel Villamayor Alilio, PharmD Candidate 2018 Thao K. Huynh, PharmD, BCOP University of Pittsburgh School of...
Friday, September 2, 2016   (0 Comments - view/add)
ZepatierTM: A New Alternative Oral Treatment for Hepatitis C Virus »
Elizabeth Bracco, PharmD Candidate 2017 Amanda Gerberich, PharmD Candidate 2017 Jaclyn Werkheiser, PharmD Candidat...
Monday, August 1, 2016   (0 Comments - view/add)
Round 2: The Second Match Phase and You »
Round 2: The Second Phase Match and You by Forrest N. Ridgway, PharmD As many of you may now know, the 2016 America...

Displaying page 1 of 2
1  |  2

Membership Management Software Powered by YourMembership  ::  Legal